HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ralph A. Schmid Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frese, S. Articles by Schmid, R. A. Search for Related Content PubMed PubMed Citation Articles by Frese, S. Articles by Schmid, R. A. Related Collections Molecular biology

J Thorac Cardiovasc Surg 2003;126:748-754
© 2003 The American Association for Thoracic Surgery

General thoracic surgery

Cell death induced by down-regulation of heat shock protein 70 in lung cancer cell lines is p53-independent and does not require DNA cleavage

^a From the Division of General Thoracic Surgery, University Hospital, Berne, Switzerland
^b Apoptosis Laboratory, Danish Cancer Society, Copenhagen, Denmark
^c Novartis, Basel, Switzerland

Received for publication November 1, 2001; accepted for publication January 21, 2003.

^* Address for reprints: Steffen Frese, MD, Department of Clinical Research, Murtenstrasse 35 Room C807, CH-3010, Berne, Switzerland
steffen.frese{at}web.de

	Abstract

Top Abstract Material and methods Results Discussion References

 
OBJECTIVE: The inducible form of heat shock protein 70 is known to be overexpressed in tumors and seems to be necessary for the survival of tumor cells via an unknown mechanism. We therefore evaluated whether selective depletion of heat shock protein 70 induces cell death in lung cancer cells.

METHODS: An adenovirus expressing antisense heat shock protein 70 and an adenovirus with ß-galactosidase were used for transduction of the lung cancer cell lines A549, NCI-H358, LXF-289, LOU-NH91, normal human bronchial epithelial cells, and normal lung fibroblasts IMR90. Cell death was determined by morphology, propidium iodide uptake, and trypan blue staining; DNA cleavage was assessed by terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling. Expression of heat shock protein 70, heat shock cognate 70, and phosphorylated p53 was determined by Western blot analysis.

RESULTS: Transduction of lung cancer cells with adenovirus expressing antisense heat shock protein 70 but not with adenovirus with ß-galactosidase resulted in extensive cell death after 96 hours (A549: 53.2 ± 9.44% versus 12.9 ± 6.6%; NCI-H358: 48.4 ± 7.2% versus 25.2 ± 1.4%; LXF-289: 58.8 ± 6.5% versus 24.7 ± 5.4%; LOU-NH91: 82.5 ± 1.8% versus 38.5 ± 2.6%). In contrast, adenovirus expressing antisense heat shock protein 70 showed much less cytotoxicity in normal human bronchial epithelial cells (16.0 ± 0.5% versus 17.1 ± 7.3%) and in normal lung fibroblasts IMR90 (17.2 ± 3.6% versus 8.2 ± 1.6%). After treatment with adenovirus expressing antisense heat shock protein 70, transactivation of p53 in A549 but not in NCI-H358, a cell line deleted for p53 has been observed. Furthermore, 22.0 ± 3.0% of A549 cells treated for adenovirus expressing antisense heat shock protein 70 stained positive with terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling versus 10.2 ± 4.0% treated with control virus. This effect but not cell death itself was blocked by treatment with 10 µmol/L zVAD-fmk, a broad caspase inhibitor.

CONCLUSIONS: Selective down-regulation of heat shock protein 70 induces cell death in lung cancer but not in normal lung cells. The demonstrated effect is p53-independent and does not require DNA cleavage. The data suggest that gene transfer of antisense heat shock protein 70 might be useful in developing new strategies for the treatment of lung cancer.

Current protocols for therapy of NSCLC include surgery and radiotherapy and chemotherapy.² Administration of radiotherapy or chemotherapy leads to the induction of programmed cell death or apoptosis. The effectiveness of the nonsurgical treatment modalities is limited by side effects and by resistance of tumor cells to undergo cell death. Resistance of tumor cells may be explained by a failure to activate the apoptotic machinery. The underlying mechanisms are not fully understood yet, but it is believed that some proteins (for example Bcl-2, survivin, or c-FLIP) play a role as intracellular inhibitors of apoptosis.³ Similar effects have been shown for the heat shock protein (Hsp) 70.^4,5 Furthermore, it has been demonstrated that Hsp70 is overexpressed in a wide range of tumors, whereas selective depletion of Hsp70 can induce apoptosis in tumor cells.⁶

We therefore assessed in the present study (1) whether selective down-regulation of Hsp70 is able to induce cell death in lung cancer but not in normal cells and (2) whether this type of cell death requires DNA cleavage or depends on p53, a protein that is often mutated in lung cancer.

	Material and methods

Top Abstract Material and methods Results Discussion References

 
Reagents
Bradford reagent, the secondary goat anti-mouse, the monoclonal anti--tubulin antibody, and 5-bromoindolyl ß-D-galactopyranoside were purchased from Sigma Chemical Co (St Louis, Mo). The protease inhibitor cocktail was produced by Boehringer (Mannheim, Germany). Culture media and penicillin/streptomycin were purchased from Life Technologies (Paisley, UK); fetal calf serum and trypan blue solution were obtained from Biochrom (Berlin, Germany). The antibodies for Hsp70 and heat shock cognate (Hsc) 70 were from Stressgene (Victoria, Canada), and phosphorylated p53 was from Oncogene (Boston, Mass). The reagents for enhanced chemoluminescence (ECL) were produced by Amersham Pharmacia Biotech (Buckinghamshire, UK).

Tumor cell lines and cell culture
The human lung cancer cell lines A549 (nonspecified lung carcinoma) and NCI-H358 (bronchoalveolar carcinoma; both cell lines from American Type Culture Collection, Manassa, Va), LXF-289 (adenocarcinoma) and LOU-NH91 (squamous cell carcinoma; both cell lines from DSMZ, Braunschweig, Germany), and normal lung fibroblasts IMR90 (American Type Culture Collection) were cultured at 37°C and 5% CO₂ in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum and antibiotics. Normal human bronchial epithelial (NHBE) cells were obtained from Biowhittaker (Walkersville, Md). The cells were maintained in media recommended by the supplier and used within 2 to 4 passages.

Transduction with adenovirus, staining for ß-galactosidase
Cells were plated at 5 x 10⁴ cells/well in 24-well plates and allowed to attach overnight. At the day of transduction the virus was diluted in medium containing 0.5% fetal calf serum at the indicated concentrations (800 to 1600 multiplicity of infection). After removing culture medium 200 µL of virus was added to each well. The plates were gently rocked and incubated for 2 hours with rocking every 30 minutes. Subsequently the virus was removed and cells were incubated with normal culture medium. The viruses used for this study were: adenovirus expressing Hsp70 (Ad.asHsp70) harboring a part of human Hsp70 sequence in antisense orientation as described elsewhere⁶ and adenovirus with ß-galactosidase (Ad.ß-gal) containing the ß-galactosidase gene kindly provided by Novartis Inc (Basel, Switzerland). Both viruses are deleted for the whole E1 and the majority of E3 region and were propagated in 293 or S8 cells.

To determine transduction efficiency, staining for ß-galactosidase was performed 24 hours after transduction with Ad.ß-gal. Cells were washed with phosphate-buffered saline (PBS), then fixed with 0.25% glutaraldehyde for 15 minutes, washed again with PBS 3 times, and staining solution (0.4 mg/mL 5-bromoindolyl ß-D-galactopyranoside, 2 mmol/L MgCl₂, 5 mmol/L K₄Fe(CN)₆, K₃Fe(CN)₆ solved in PBS) was added. After an incubation period of 24 hours at 37°C, the stain was analyzed.

Trypan blue staining, prodidium iodide uptake
Trypan blue staining and propidium iodide uptake were used to measure the viability of cells. After the indicated time, cells were harvested by trypsinization. For trypan blue staining, cells were centrifuged and resuspended in 100 µL PBS; 100 µL of 0.5% trypan blue solution was added and probes were incubated for 5 minutes at 37°C. The percentage of dead blue cells was determined by using a hemocytometer and by counting a minimum of 100 cells per sample. Because NHBE cells were clumping when stained with trypan blue, propidium iodide uptake was used to determine cell death. After harvesting the cells, propidium iodide was added to a final concentration of 10 µg/mL and samples were immediately analyzed by FACScan (Becton Dickinson, San Jose, Calif). A minimum of 1 x 10⁴ cells per sample was analyzed. All experiments were performed in triplicate.

Terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling staining
DNA cleavage was assessed by a terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling (TUNEL) kit (Roche, Mannheim, Germany) following the manufacturer’s instructions. In brief, cells were harvested, fixed for 30 minutes at room temperature with 4% paraformaldehyde, washed with PBS, then permeabilized with buffer containing 0.1% Triton X-100 and 0.1% sodium citrate for 2 minutes on ice and washed again with PBS. Cells were than incubated with 50 µL reaction mixture and incubated for 1 hour at 37°C. Percentage of TUNEL positive cells was determined by flow cytometry using a FACScan and analyzing a minimum of 1 x 10⁴ cells per sample.

Western blot
Western blot was performed as described elsewhere.⁷ In brief, cells were harvested and then lysed for 30 minutes on ice in a buffer containing 20 mmol/L HEPES, pH 7.6; 120 mmol/L NaCl; 0.2 mmol/L ethylenediaminetetraacetic acid; 1% Triton X-100; and protease inhibitors. Lysates were centrifuged at 14,000 rpm for 15 minutes, and supernatants were collected. Protein concentration was determined with Bradford reagent. Proteins were separated by denaturating gel electrophoresis. The proteins were transferred to nitrocellulose membranes and incubated with blocking buffer (20 mmol/L Tris-HCL, pH 7.5; 500 mmol/L NaCl; 0.05% Tween20, 5% milk powder). After washing with buffer containing 20 mmol/L Tris-HCl (pH 7.5), 500 mmol/L NaCl, and 0.05% Tween20, blots were incubated with the primary antibodies diluted in blocking solution. After a second wash the blots were incubated with horseradish peroxidase–coupled secondary antibody, washed again, and developed with ECL.

For stripping, membranes were incubated for 30 minutes at 50°C in a buffer containing 62.5 mmol/L Tris-HCl (pH 6.7), 2% sodium dodecyl sulfate, 100 mmol/L ß-meraptoethanol. Then the blots were washed and blocked again.

Statistics
Data are expressed as mean ± SD. Statistical significance was determined using one-way analysis of variance followed by Bonferroni’s t test. Values of P < .05 were considered significant.

	Results

Top Abstract Material and methods Results Discussion References

 
Expression of Hsp70 in lung cancer and normal lung cells
Expression level of Hsp70 was determined by Western blot. The experiment revealed that Hsp70 is highly expressed in 3 out of 4 lung cancer cells lines. In normal lung fibroblasts, IMR90, there was only a faint band for the expression of Hsp70 detectable. Interestingly, NHBE cells showed an Hsp70 expression comparable to the expression of the 3 lung cancer cell lines A549, NCI-H358, and LXF-289 (Figure 1).

View larger version (29K): [in this window] [in a new window]   Figure 1. Expression of Hsp70 in the lung cancer cell lines A549, NCI-H358, LXF-289, and LOU-NH91, normal lung fibroblasts IMR90, and normal human bronchial epithelial (NHBE) cells. Expression of Hsp70 was assessed by Western blot. To show equal amounts of protein the blot was stripped and reincubated with an antibody against -tubulin.

View larger version (46K): [in this window] [in a new window]   Figure 2. Selective down-regulation of Hsp70 by Ad.asHsp70. A549 and NHBE cells were transduced with Ad.asHsp70 and lysed at the indicated time points. Expression of Hsp70 was determined by Western blot; the same blot was stripped and developed with an anti-Hsc70 antibody.

View larger version (91K): [in this window] [in a new window]   Figure 3. Transduction efficiency and morphologic changes in IMR90 (A), NHBE (B), and A549 (C) after treatment with Ad.asHsp70 and Ad.ß-gal. To detect transduction efficiency, cells were stained 24 hours after transduction with Ad.ß-gal for ß-galactosidase (A through C, first column). Changes in morphology 96 hours after transduction were determined by light microscopy (A through C, columns 2 and 3). To assess caspase dependence, A549 in addition to Ad.asHsp70 were treated with 10 µmol/L zVAD, a caspase inhibitor. After 48 hours of incubation medium was changed and fresh zVAD was added (C, column 4).

Cell death after treatment with Ad.asHsp70
Cell death was assessed by trypan blue exclusion or propidium uptake 96 hours after transduction. According to the changes in morphology, lung cancer cells transduced with Ad.asHsp70, in comparison with those transduced with Ad.ß-gal, showed extensive cell death (mean ± SD: A549: 53.2 ± 9.44% versus 12.9 ± 6.6%; NCI-H358: 48.4 ± 7.2% versus 25.2 ± 1.4%; LXF-289: 58.8 ± 6.5% versus 24.7 ± 5.4%; LOU-NH91: 82.5 ± 1.8% versus 38.5 ± 2.6%; P < .001 for Ad.asHsp70-treated cells compared with nontreated cells and P > .05 for Ad.ß-gal-treated cells versus nontreated cells). In contrast, depletion of Hsp70 by Ad.asHsp70 revealed no significant cytotoxicity in normal lung fibroblasts IMR90 (17.2 ± 3.6% versus 8.2 ± 1.6%) or in primary human bronchial epithelial cells (16.0 ± 0.5% versus 17.1 ± 7.3%; Figure 4).

View larger version (20K): [in this window] [in a new window]   Figure 4. Viability of lung cancer cells, lung fibroblasts, and NHBE cells after transduction with Ad.asHsp70 and Ad.ß-gal. Cells were transduced with Ad.asHsp70 or Ad.ß-gal, achieving 90% to 100% transduction efficiency; 96 hours after transduction, cells were stained with trypan blue. zVAD was used in a concentration of 10 µmol/L, changing medium after 48 hours. For NHBE cells, cell death was determined by staining with propidium iodide followed by FACScan analysis. Experiments were performed in triplicates. *P < .001 and **P < .01 (mean ± SD) compared with nontreated cells.

View larger version (17K): [in this window] [in a new window]   Figure 5. Cell death induced by down-regulation of Hsp70 does not depend on p53. A549 and NCI-H358 cells were treated as indicated. Virus-treated cells were lysed 96 hours after transduction. Activated p53 phosphorylated on serine 15 was determined by Western blot. To confirm equal protein levels the same blot was stripped and developed with an anti--tubulin antibody.

View larger version (15K): [in this window] [in a new window]   Figure 6. DNA cleavage is not essential for cell death induced by depletion of Hsp70. A549 cells were transduced with Ad.asHsp70 or Ad.ß-gal as indicated. zVAD was used in a concentration of 10 µmol/L; fresh zVAD was added after 48 hours. Cells were harvested after 96 hours, and TUNEL staining was performed followed by flow cytometry. *P < .001 versus Ad.ß-Gal (mean ± SD of 4 independent experiments).

	Discussion

Top Abstract Material and methods Results Discussion References

Based on this background, it was hypothesized that down-regulation of Hsp70 would render tumor cells susceptible to proapoptotic stimuli. This was demonstrated by Robertson and colleagues,¹⁴ who showed synergistic effects of Hsp70 antisense oligomers and proteasome inhibitors. Surprisingly, 2 other studies demonstrated that depletion of Hsp70 by antisense alone is sufficient to induce cell death in tumor cells. Kaur and colleagues¹⁵ induced cell death in human oral cancer cells using Hsp70 antisense oligonucleotides, whereas Nylandsted and colleagues⁶ treated human breast carcinoma cells with an adenovirus expressing an Hsp70 sequence in antisense orientation. The same virus was used in our study to evaluate whether lung cancer cells undergo cell death when Hsp70 is down-regulated. We could demonstrate that the lung cancer cell lines used, but not normal lung fibroblasts or normal human bronchial epithelial cells, underwent cell death. Therefore, these data strongly support the idea that down-regulation of Hsp70 induces tumor-specific cell death. However, when comparing the data of expression of Hsp70 in the cancer and normal lung cells with the rate of cell death induced by down-regulation of Hsp70, there was no correlation between expression level and the extent of cell death. One might speculate from this whether in certain types of cancer cells different cellular factors are necessary for survival. The data also suggest that overexpression of Hsp70 alone does not account for the decision to be a cancer cell or not.

Why and how tumor cells die from selective depletion of Hsp70 is not known yet. Nylandsted and colleagues⁶ suggested that down-regulation of Hsp70 induces a specific form of apoptosis or programmed cell death that is caspase-independent and cannot be blocked by overexpression of Bcl-2.

Our data indicate that cell death induced by down-regulation of Hsp70 is not p53-dependent. p53 is a tumor suppressor gene that is frequently mutated in human cancer. A nonfunctional p53 gene can render tumor cells resistant to proapoptotic stimuli.¹⁶ Consequently, there is a need for antitumor strategies that are p53-independent, as we have shown in the present study for selective depletion of Hsp70. Also important, by demonstrating the difference in activity of p53 in lung cancer cells treated with Ad.asHsp70 or with control virus Ad.ß-gal, these data give some more evidence that the observed cell death after treatment with Ad.asHsp70 is due to depletion of Hsp70 and not an artifact of the adenovirus itself.

In addition to p53, we examined whether tumor-selective cell death induced by Hsp70 depletion depends on nuclear changes—for example, DNA fragmentation caused either by activation of caspase-activated DNase (CAD)¹⁷ or by activation of mitochondrial apoptosis-inducing factor (AIF).¹⁸ Although activation of CAD requires activation of caspases, mitochondrial AIF acts in a caspase-independent manner. Therefore, if cell death induced by down-regulation of Hsp70 is a form of caspase-independent apoptosis,⁶ mitochondrial AIF would be most likely a downstream target. This hypothesis is supported by data from Ravagnan and colleagues¹⁹ showing an interaction between Hsp70 and mitochondrial AIF and demonstrating that Hsp70 is able to block mitochondrial AIF. Our own findings do not confirm the idea that mitochondrial AIF is involved in this form of cell death. In contrast, our results suggest that DNA fragmentation itself is not essential, which might indicate that cytosolic changes are more important for cell death induced by depletion of Hsp70. Similar data showing that DNA damage is only of minor importance for cell death have been demonstrated for ultraviolet-induced apoptosis.²⁰ Remarkably, Nylandsted and colleagues⁶ conclude from morphologic evaluation of nuclear changes by electron microscopy that cell death induced by down-regulation of Hsp70 is a form of apoptosis. Because we hypothesized a minor importance for nuclear changes, our data do not support the idea that down-regulation of Hsp70 initiates apoptosis. Which kind of cell death is based on down-regulation of Hsp70 and how it is mediated on cellular level needs further evaluation.

In conclusion, the present study demonstrates that adenovirus-mediated selective depletion of Hsp70 can efficiently induce cell death in lung cancer cells but not in normal lung fibroblasts. Furthermore, it shows that this effect does not depend on p53 and DNA fragmentation. Therefore, it might help to develop new therapeutic p53-independent strategies for the treatment of lung cancer. Further in vivo studies in our group will prove whether cell death induced by depletion of Hsp70 will also efficiently work in primary culture of lung cancer derived from patient material. Preliminary results from these experiments show that it is difficult to achieve high transduction efficiency. Encouraged by other promising studies using adenovirus-mediated gene transfer,^21,22 we hope to solve the problems of transduction efficiency to obtain more preclinical data for the induction of cell death by antisense Hsp70 treatment in lung cancer.

	Footnotes

 
Supported by grants from the Bernensis Cancer League, Berne, Switzerland (BKL 61), and Novartis Foundation, Basel, Switzerland (00B33).

	References

Top Abstract Material and methods Results Discussion References

 

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999 (see comments). CA Cancer J Clin. 1999;49:8–31[Abstract/Free Full Text]
   
2. Eberhardt W, Bildat S, Korfee S. Combined modality therapy in NSCLC. Ann Oncol. 2000;11(Suppl 3):85–95[Abstract/Free Full Text]
   
3. Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res. 1999;248:30–43[Medline]
   
4. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000;92:1564–1572[Abstract/Free Full Text]
   
5. Creagh EM, Sheehan D, Cotter TG. Heat shock proteins—modulators of apoptosis in tumour cells. Leukemia. 2000;14:1161–1173[Medline]
   
6. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci U S A. 2000;97:7871–7876[Abstract/Free Full Text]
   
7. Frese S, Brunner T, Gugger M, Stein R, Schmid RA. Apo2L/TRAIL-induced apoptosis in NSCLC cell lines is enhanced by chemotherapeutic agents but not correlated to the expression level of c-FLIP. J Thorac Cardiovasc Surg. 2002;123:159-63
   
8. Mukhopadhyay T, Roth JA. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene. 1997;14:379–384[Medline]
   
9. Takahashi T, Carbone D, Nau MM, et al. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res. 1992;52:2340–2343[Abstract/Free Full Text]
   
10. Dumaz N, Meek DW. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 1999;18:7002–7010[Medline]
    
11. Maehara Y, Oki E, Abe T, et al. Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology. 2000;58:144–151[Medline]
    
12. Malusecka E, Zborek A, Krzyzowska-Gruca S, Krawczyk Z. Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study. Anticancer Res. 2001;21:1015–1021[Medline]
    
13. Beere HM, Wolf BB, Cain K, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000;2:469–475[Medline]
    
14. Robertson JD, Datta K, Biswal SS, Kehrer JP. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis. Biochem J. 1999;344:477–485
    
15. Kaur J, Ralhan R. Induction of apoptosis by abrogation of HSP70 expression in human oral cancer cells. Int J Cancer. 2000;85:1–5[Medline]
    
16. Wallace-Brodeur RR, Lowe SW. Clinical implications of p53 mutations. Cell Mol Life Sci. 1999;55:64–75[Medline]
    
17. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res. 2000;256:12–18[Medline]
    
18. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397:441–446[Medline]
    
19. Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001;3:839–843[Medline]
    
20. Kulms D, Poppelmann B, Schwarz T. Ultraviolet radiation-induced interleukin 6 release in HeLa cells is mediated via membrane events in a DNA damage-independent way. J Biol Chem. 2000;275:15060–15066[Abstract/Free Full Text]
    
21. Nemunaitis J, Swisher SG, Timmons T, et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol. 2000;18:609–622[Abstract/Free Full Text]
    
22. Khuri FR, Nemunaitis J, Ganly I, et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med. 2000;6:879–885[Medline]
    

This article has been cited by other articles:

				C. A. Culver and S. M. Laster Adenovirus Type 5 Exerts Multiple Effects on the Expression and Activity of Cytosolic Phospholipase A2, Cyclooxygenase-2, and Prostaglandin Synthesis J. Immunol., September 15, 2007; 179(6): 4170 - 4179. [Abstract] [Full Text] [PDF]

				S. Frese, M. Frese-Schaper, A.-C. Andres, D. Miescher, B. Zumkehr, and R. A. Schmid Cardiac Glycosides Initiate Apo2L/TRAIL-Induced Apoptosis in Non-Small Cell Lung Cancer Cells by Up-regulation of Death Receptors 4 and 5 Cancer Res., June 1, 2006; 66(11): 5867 - 5874. [Abstract] [Full Text] [PDF]

				T. Mijatovic, A. Op De Beeck, E. Van Quaquebeke, J. Dewelle, F. Darro, Y. de Launoit, and R. Kiss The cardenolide UNBS1450 is able to deactivate nuclear factor {kappa}B-mediated cytoprotective effects in human non-small cell lung cancer cells. Mol. Cancer Ther., February 1, 2006; 5(2): 391 - 399. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ralph A. Schmid Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frese, S. Articles by Schmid, R. A. Search for Related Content PubMed PubMed Citation Articles by Frese, S. Articles by Schmid, R. A. Related Collections Molecular biology